Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the ...
Native Instruments has unveiled Maschine 3.4, the latest update to its acclaimed hybrid production and performance platform. This release delivers a powerful modulation editor redesign, expanded Play ...
Amid much debate about the health of the art market, Frieze is back in London, with its two fairs, Frieze London and Frieze Masters. Ben Luke talks to The Art Newspaper’s art market editor, Kabir ...
Native Instruments has officially unveiled Odes, the third chapter in its acclaimed Evolution series, following the beloved Lores and Fables libraries. Designed to add tension, emotion, and movement ...
Native Instruments has introduced the Traktor MX2, a compact two-channel DJ controller designed to deliver creative control to DJs at any level. The all-black unit is a super sleek follow up to its ...
Native Instruments has introduced the Traktor MX2, a next-generation 2-channel DJ controller aimed at DJs of all levels. This is the first Traktor controller that we’ve seen in years – the renewed Z1 ...
LAS VEGAS - Hypha Labs, Inc. (OTCQB:FUNI), a micro-cap biotech company with a current market value of $3.41 million, announced Wednesday the launch of Phase II in its strategic partnership with ...
LAS VEGAS, NV, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the ...
LAS VEGAS, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the official ...
LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it ...
LAS VEGAS - Hypha Labs, Inc. (OTCQB:FUNI), a micro-cap biotechnology company currently valued at $3.85 million and trading below its InvestingPro Fair Value, has entered an agreement with Automated ...